Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited ( (AU:EBO) ) has shared an update.
EBOS Group Limited has issued 5,553 fully paid ordinary shares at NZ$23.04 per share under its Employee Share Plan, following a directors’ resolution. The new shares, representing approximately 0.0027% of the company’s ordinary share capital, bring the total number of ordinary shares on issue to 206,929,602 and modestly dilute existing holders while reinforcing staff ownership incentives.
The capital change is small in scale but signals EBOS’s continued use of equity-based remuneration to align employees with shareholder interests. Maintaining an active employee share plan may aid talent retention and engagement in a competitive healthcare distribution market, while the minimal increase in issued capital limits any material impact on overall shareholder value or control dynamics.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$29.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a healthcare and animal care company listed on the NZX under ticker EBO, with a primary focus on distributing pharmaceuticals, medical supplies, and related products across Australasia. The group also operates in adjacent healthcare services and consumer products markets, supporting hospitals, pharmacies, and veterinary channels in New Zealand and Australia.
Average Trading Volume: 155,480
Technical Sentiment Signal: Sell
Current Market Cap: A$3.89B
Learn more about EBO stock on TipRanks’ Stock Analysis page.

